Compare Honest Company Inc (HNST) vs Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honest Company Inc vs Maravai LifeSciences Holdings Inc. Class A Common Stock — how do they compare? Honest Company Inc trades at $5.05 (market cap $543.40M), while Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M). The key difference: Maravai LifeSciences Holdings Inc. Class A Common Stock is the larger of the two by market cap, and Honest Company Inc is trading nearer its 52-week high, Maravai LifeSciences Holdings Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Honest Company Inc for 39 Days and Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days on average.
| HNST | MRVI | |
|---|---|---|
Market Cap | $543.40M | $977.37M |
Volume | 1,509,522 | 2,742,564 |
Sector | Consumer Staples | Health |
52-Week High | $5.95 | $9.00 |
52-Week Low | $2.10 | $2.83 |
Typical Hold Time | 39 Days | 0 Days |
Enterprise Value | $447.00M | $1.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HNST trades at $5.19, up 0.58% today, with a neutral technical signal and mixed earnings performance. The company shows improving cash flow trends with $14.15M net cash flow in 2025, though revenue declined to $371.32M with a net loss of $15.69M. Recent Q2 2026 earnings beat expectations with $0.04 EPS, while strategic exits continue to reshape the business.
The stock presents a turnaround story with improving profitability metrics but faces execution risks amid revenue pressure. Analyst consensus is mixed with a $5.30 price target, representing modest upside potential. Key risks include sustained profitability challenges and competitive pressures in the personal care sector.
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →
